Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 ; volume:16 ; number:1 ; day:23 ; month:1 ; year:2014 ; pages:1-11 ; date:2.2014
Breast cancer research ; 16, Heft 1 (23.1.2014), 1-11, 2.2014
- Urheber
-
De Giovanni, Carla
- Beteiligte Personen und Organisationen
-
Nicoletti, Giordano
Quaglino, Elena
Landuzzi, Lorena
Palladini, Arianna
Ianzano, Marianna Lucia
Dall’Ora, Massimiliano
Grosso, Valentina
Ranieri, Dario
Laranga, Roberta
Croci, Stefania
Amici, Augusto
Penichet, Manuel L.
Iezzi, Manuela
Cavallo, Federica
Nanni, Patrizia
Lollini, Pier-Luigi
SpringerLink (Online service)
- DOI
-
10.1186/bcr3602
- URN
-
urn:nbn:de:1111-2016032419272
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- De Giovanni, Carla
- Nicoletti, Giordano
- Quaglino, Elena
- Landuzzi, Lorena
- Palladini, Arianna
- Ianzano, Marianna Lucia
- Dall’Ora, Massimiliano
- Grosso, Valentina
- Ranieri, Dario
- Laranga, Roberta
- Croci, Stefania
- Amici, Augusto
- Penichet, Manuel L.
- Iezzi, Manuela
- Cavallo, Federica
- Nanni, Patrizia
- Lollini, Pier-Luigi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dual targeting non-overlapping epitopes in HER2 domain IV substantially enhanced HER2/HER2 homodimers and HER2/EGFR heterodimers internalization leading to potent antitumor activity in HER2-positive human gastric cancer
The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
The role of histone 2B monoubiquitination (H2Bub1) in HER2-driven mammary carcinoma
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
Dual targeting non-overlapping epitopes in HER2 domain IV substantially enhanced HER2/HER2 homodimers and HER2/EGFR heterodimers internalization leading to potent antitumor activity in HER2-positive human gastric cancer
The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
The role of histone 2B monoubiquitination (H2Bub1) in HER2-driven mammary carcinoma
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
Dual targeting non-overlapping epitopes in HER2 domain IV substantially enhanced HER2/HER2 homodimers and HER2/EGFR heterodimers internalization leading to potent antitumor activity in HER2-positive human gastric cancer
The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
The role of histone 2B monoubiquitination (H2Bub1) in HER2-driven mammary carcinoma
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis